AbstractBackgroundActive surveillance (AS) is commonly used for men with low-risk prostate cancer (PCa). When life expectancy becomes too short for curative treatment to be beneficial, a change from AS to watchful waiting (WW) follows. Little is known about this change since it is rarely documented in medical records.ObjectiveTo model transition from AS to WW and how this is affected by age and comorbidity among men with very low-risk PCa.Design, setting, and participantsNational population-based healthcare registers were used for analysis.Outcome measurements and statistical analysisUsing data on PCa characteristics, age, and comorbidity, a state transition model was created to estimate the probability of changes between predefined treatme...
IMPORTANCE: The long-term outcomes among men with prostate cancer (PC) whose disease is managed with...
Purpose The suitability of younger patients with prostate cancer (PCa) for initial active surveillan...
To compare the clinical outcome of males with low-risk and favorable intermediate-risk prostate canc...
Background: Active surveillance (AS) is commonly used for men with low-risk prostate cancer (PCa). W...
PurposeUrologists have been criticized for overtreating men with low risk prostate cancer and f...
PurposeWatchful waiting (WW) is one option for men with clinically localized prostate cancer. We exa...
Background: Regional differences in active surveillance (AS) uptake for prostate cancer (PC) illustr...
BACKGROUND: A significant proportion of screen-detected men with prostate cancer may be overdiagnose...
Background: Careful assessment of the reasons for discontinuation of active surveillance (AS) is req...
BACKGROUND: Active surveillance (AS) is a management option for men diagnosed with low-risk prosta...
BackgroundActive surveillance (AS) is a management option for men diagnosed with low-risk prostate c...
Active surveillance (AS) is a management strategy involving close monitoring the course of disease w...
BackgroundActive surveillance followed by selective treatment for men who have evidence of disease p...
This is the author accepted manuscript. The final version is available from Wiley via the DOI in thi...
Background. Men with a low-risk prostate cancer (PCa) should consider observation, particularly acti...
IMPORTANCE: The long-term outcomes among men with prostate cancer (PC) whose disease is managed with...
Purpose The suitability of younger patients with prostate cancer (PCa) for initial active surveillan...
To compare the clinical outcome of males with low-risk and favorable intermediate-risk prostate canc...
Background: Active surveillance (AS) is commonly used for men with low-risk prostate cancer (PCa). W...
PurposeUrologists have been criticized for overtreating men with low risk prostate cancer and f...
PurposeWatchful waiting (WW) is one option for men with clinically localized prostate cancer. We exa...
Background: Regional differences in active surveillance (AS) uptake for prostate cancer (PC) illustr...
BACKGROUND: A significant proportion of screen-detected men with prostate cancer may be overdiagnose...
Background: Careful assessment of the reasons for discontinuation of active surveillance (AS) is req...
BACKGROUND: Active surveillance (AS) is a management option for men diagnosed with low-risk prosta...
BackgroundActive surveillance (AS) is a management option for men diagnosed with low-risk prostate c...
Active surveillance (AS) is a management strategy involving close monitoring the course of disease w...
BackgroundActive surveillance followed by selective treatment for men who have evidence of disease p...
This is the author accepted manuscript. The final version is available from Wiley via the DOI in thi...
Background. Men with a low-risk prostate cancer (PCa) should consider observation, particularly acti...
IMPORTANCE: The long-term outcomes among men with prostate cancer (PC) whose disease is managed with...
Purpose The suitability of younger patients with prostate cancer (PCa) for initial active surveillan...
To compare the clinical outcome of males with low-risk and favorable intermediate-risk prostate canc...